Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 4/20 | 0.43 |
| ▸ | CTSL | P07711 | 3/20 | 0.43 |
| ▸ | CAPN1 | P07384 | 3/20 | 0.43 |
| ▸ | CTSS | P25774 | 3/20 | 0.43 |
| ▸ | CTSK | P43235 | 2/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | PIN1 | Q13526 | 4/20 | 0.41 |
| ▸ | ACE | P12821 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CCKAR | P32238 | 1/20 | 0.39 |
| ▸ | CCKBR | P32239 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CCR1 | P32246 | 1/20 | 0.38 |
| ▸ | CTSV | O60911 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7693478 | 0.91 | ACE (0.45) | CTSBCTSLCAPN1CTSSCTSK | |
| SCHEMBL7694857 | 0.87 | CA2 (0.43) | CTSBCTSLCAPN1CTSSCTSK | |
| SCHEMBL7701518 | 0.84 | CA2 (0.44) | CTSBCTSLCAPN1CASP1PIN1 | |
| SCHEMBL7695603 | 0.79 | CAPN1 (0.70) | CTSBCTSLCAPN1CTSSCTSK | |
| SCHEMBL7694848 | 0.78 | PTPN1 (0.55) | CTSBCTSLCAPN1CTSSCTSK | |
| SCHEMBL7696723 | 0.77 | CTSS (0.50) | CTSBCTSLCTSSCTSKCASP1 | |
| SCHEMBL7698402 | 0.77 | CHRNB2 (0.52) | CTSBCTSLCAPN1CTSSCTSK | |
| SCHEMBL7689558 | 0.76 | ALDH1A1 (0.55) | CTSBCTSLCTSSCTSKCA2 | |
| SCHEMBL7694696 | 0.75 | KDM4E (0.47) | CTSSCTSKL3MBTL1 | |
| SCHEMBL7695396 | 0.72 | AKR1C3 (0.48) | CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6436925-B1 | BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES | ABBOTT LABORATORIES | 2002-08-20 | — | — | US | disclosed |